
  
    
      
        Background_NNP
        The_DT complete_JJ sequencing_VBG of_IN several_JJ genomes_NNS ,_, including_VBG
        that_IN of_IN the_DT human_NN ,_, has_VBZ signaled_VBN the_DT beginning_NN of_IN a_DT new_JJ era_NN
        in_IN which_WDT scientists_NNS are_VBP becoming_VBG increasingly_RB interested_JJ in_IN
        functional_JJ genomics_NNS ;_: that_DT is_VBZ ,_, uncovering_VBG both_DT the_DT
        functional_JJ roles_NNS of_IN different_JJ genes_NNS ,_, and_CC how_WRB these_DT genes_NNS
        interact_NN with_IN ,_, and_CC /_NN or_CC influence_NN ,_, each_DT other_JJ ._. Increasingly_RB ,_,
        this_DT question_NN is_VBZ being_VBG addressed_VBN through_IN the_DT simultaneous_JJ
        analysis_NN of_IN hundreds_NNS to_TO thousands_NNS of_IN unique_JJ genetic_JJ
        elements_NNS with_IN microarrays_NNS ._. Already_RB ,_, analytical_JJ strategies_NNS
        have_VBP subdivided_JJ into_IN distinct_JJ '_POS omic_JJ '_POS domains_NNS ,_, such_JJ as_IN
        genomics_NNS ,_, proteomics_NNS ,_, and_CC metabolomics_NNS ._. This_DT enables_VBZ
        researchers_NNS to_TO examine_VB not_RB only_RB genetic_JJ elements_NNS ,_, but_CC also_RB
        the_DT corresponding_JJ proteins_NNS and_CC metabolites_NNS derived_VBN from_IN
        these_DT genes_NNS ._. All_NNP '_POS omic_JJ '_POS technologies_NNS share_VBP the_DT need_NN for_IN
        fresh_JJ ,_, innovative_JJ looks_NNS at_IN data_NNS analysis_NN ._. To_TO date_NN ,_,
        transcriptomics_NNS is_VBZ the_DT most_RBS widely_RB studied_VBN molecular_JJ
        approach_NN ,_, enabling_VBG researchers_NNS to_TO examine_VB subtle_JJ
        differences_NNS in_IN thousands_NNS of_IN mRNA_NN levels_NNS between_IN
        experimental_JJ samples_NNS ,_, medical_JJ biopsies_NNS ,_, 
        etc_FW ._. Although_IN mRNA_NN is_VBZ not_RB the_DT end_NN
        product_NN of_IN a_DT gene_NN ,_, the_DT transcription_NN of_IN a_DT gene_NN is_VBZ both_DT
        critical_JJ and_CC highly_RB regulated_VBN ,_, thereby_RB providing_VBG an_DT ideal_JJ
        point_NN of_IN investigation_NN [_NN 1_CD 2_CD ]_NN ._. Development_NNP of_IN microarrays_NNS
        has_VBZ permitted_VBN global_JJ measurement_NN of_IN gene_NN expression_NN at_IN the_DT
        transcript_NN level_NN and_CC provided_VBD a_DT glimpse_NN into_IN the_DT
        coordinated_VBN control_NN and_CC interactions_NNS between_IN genes_NNS ._.
        Presently_NNP ,_, two_CD technologies_NNS dominate_VBP the_DT field_NN of_IN
        high-density_JJ microarrays_NNS :_: cDNA_NN arrays_NNS and_CC oligonucleotide_NN
        arrays_NNS ._. The_DT cDNA_NN array_NN has_VBZ a_DT long_JJ history_NN of_IN development_NN [_NN
        3_CD ]_NN stemming_VBG from_IN immunodiagnostic_JJ work_NN in_IN the_DT 1980_CD s_VBZ ;_:
        however_RB ,_, it_PRP has_VBZ been_VBN most_RBS widely_RB developed_VBN in_IN recent_JJ years_NNS
        by_IN Stanford_NNP University_NNP (_( California_NNP )_) researchers_NNS depositing_VBG
        cDNA_NN tags_NNS onto_IN glass_NN slides_NNS ,_, or_CC chips_NNS ,_, with_IN precise_JJ robotic_JJ
        printers_NNS [_NN 4_CD ]_NN ._. Labeled_NNP cDNA_NN fragments_NNS are_VBP then_RB hybridized_JJ
        to_TO the_DT tags_NNS on_IN the_DT chip_NN ,_, scanned_JJ ,_, and_CC differences_NNS in_IN mRNA_NN
        between_IN samples_NNS identified_VBN and_CC visualized_JJ using_VBG a_DT variation_NN
        of_IN the_DT red_JJ /_NN green_JJ matrix_NN originally_RB introduced_VBN by_IN Eisen_NNP and_CC
        colleagues_NNS [_NN 5_CD ]_NN ._. The_DT light-generated_JJ oligonucleotide_NN
        array_NN ,_, developed_VBN by_IN Affymetrix_NNP ,_, Inc_NNP ._. (_( Santa_NNP Clara_NNP ,_, CA_NNP )_) ,_,
        involves_VBZ synthesizing_VBG short_JJ 25_CD -_: mer_NN oligonucleotide_NN probes_NNS
        directly_RB onto_IN a_DT glass_NN slide_NN using_VBG photolithographic_JJ masks_NNS [_NN
        6_CD 7_CD ]_NN ._. Sample_NNP processing_NN includes_VBZ the_DT production_NN of_IN
        labeled_VBN cRNA_NN ,_, hybridization_NN to_TO a_DT microarray_NN ,_, and_CC
        quantification_NN of_IN the_DT obtained_VBN signal_NN after_IN laser_NN scanning_VBG ._.
        Regardless_RB of_IN the_DT array_NN used_VBD ,_, the_DT output_NN can_MD be_VB readily_RB
        transferred_VBN to_TO commercially_RB available_JJ data_NNS analysis_NN
        programs_NNS for_IN the_DT selection_NN and_CC clustering_VBG of_IN significantly_RB
        modified_VBN genes_NNS ._.
        Differentially_NNP expressed_VBD genes_NNS will_MD be_VB defined_VBN herein_NN as_IN
        gene_NN data_NNS determined_VBN to_TO be_VB statistical_JJ outliers_NNS from_IN some_DT
        standard_JJ state_NN ,_, and_CC which_WDT can_MD not_RB be_VB ascribed_VBN to_TO chance_NN or_CC
        natural_JJ variabilty_NN ._. Various_JJ creative_JJ techniques_NNS have_VBP been_VBN
        proposed_VBN and_CC implemented_VBN for_IN the_DT selection_NN of_IN
        differentially_RB expressed_VBD genes_NNS ;_: however_RB ,_, none_NN have_VBP yet_RB
        gained_VBN widespread_JJ acceptance_NN for_IN microarray_NN analysis_NN ._.
        Despite_IN this_DT ,_, there_EX remains_VBZ a_DT great_JJ impulse_NN to_TO develop_VB new_JJ
        data_NNS analysis_NN techniques_NNS ,_, partly_RB driven_VBN by_IN the_DT obvious_JJ need_VBP
        to_TO move_VB beyond_IN setting_VBG simple_JJ fold_VB change_NN cut-offs_JJ which_WDT
        are_VBP out_IN of_IN context_NN with_IN the_DT rest_NN of_IN the_DT experimental_JJ and_CC
        biological_JJ data_NNS at_IN hand_NN [_NN 8_CD 9_CD 10_CD 11_CD ]_NN ._. This_DT has_VBZ been_VBN the_DT
        case_NN for_IN many_JJ studies_NNS ,_, where_WRB the_DT selection_NN of_IN differential_NN
        gene_NN expression_NN is_VBZ performed_VBN through_IN a_DT simple_JJ fold_VB change_NN
        cut-off_JJ ,_, typically_RB between_IN 1_CD ._. 8_CD and_CC 3_CD ._. 0_CD ._. There_EX is_VBZ an_DT
        inherent_JJ problem_NN with_IN this_DT selection_NN criterion_NN ,_, as_IN genes_NNS of_IN
        low_JJ absolute_JJ expression_NN have_VBP a_DT greater_JJR inherent_JJ error_NN in_IN
        their_PRP$ measured_VBN levels_NNS ._. These_DT genes_NNS will_MD then_RB tend_VB to_TO
        numerically_RB meet_VB any_DT given_VBN fold_VB change_NN cut-off_JJ even_RB if_IN the_DT
        gene_NN is_VBZ not_RB truly_RB differentially_RB expressed_VBD ._. The_DT inverse_NN
        also_RB holds_VBZ true_JJ ,_, where_WRB highly_RB expressed_VBD genes_NNS ,_, having_VBG less_JJR
        error_NN in_IN their_PRP$ measured_VBN levels_NNS ,_, may_MD not_RB meet_VB an_DT arbitrary_JJ
        fold-change_JJ cut-off_JJ of_IN 2_CD ._. 0_CD even_RB when_WRB they_PRP are_VBP truly_RB
        differentially_RB expressed_VBD [_NN 12_CD ]_NN ._. Therefore_RB ,_, selecting_VBG
        differentially_RB regulated_VBN genes_NNS based_VBN only_RB on_IN a_DT single_JJ fold_VB
        change_NN across_IN the_DT entire_JJ range_NN of_IN experimental_JJ data_NNS
        preferentially_RB selects_VBZ lowly_JJ expressed_VBN genes_NNS [_NN 8_CD ]_NN ._. This_DT
        commonly_RB used_VBN approach_NN does_VBZ not_RB accommodate_VB for_IN background_NN
        noise_NN ,_, variability_NN ,_, non-specific_JJ binding_JJ ,_, or_CC low_JJ copy_NN
        numbers-_NN characteristics_NNS typical_JJ of_IN microarray_NN data_NNS which_WDT
        may_MD not_RB be_VB homogeneously_RB distributed_VBN ._. Other_JJ approaches_NNS
        entail_VB the_DT use_NN of_IN standard_JJ statistical_JJ measures_NNS such_JJ as_IN a_DT
        student_NN 's_POS 
        t_NN -_: test_NN or_CC ANOVA_NNP for_IN every_DT individual_JJ
        gene_NN ._. However_RB ,_, due_JJ to_TO the_DT cost_NN of_IN repeating_VBG microarray_NN
        experiments_NNS ,_, the_DT number_NN of_IN replicates_NNS usually_RB remains_VBZ low_JJ ,_,
        leading_VBG to_TO inaccurate_JJ estimates_NNS of_IN variance_NN [_NN 8_CD ]_NN ._.
        Furthermore_RB ,_, due_JJ to_TO the_DT low_JJ number_NN of_IN replicates_NNS ,_, the_DT power_NN
        of_IN these_DT "_'' gene-by-gene_JJ "_'' statistical_JJ tests_NNS to_TO differentiate_VB
        between_IN regulated_VBN and_CC non-regulated_JJ genes_NNS also_RB remains_VBZ very_RB
        low_JJ ._.
        The_DT present_JJ article_NN describes_VBZ a_DT model_NN that_WDT considers_VBZ
        both_DT expression_NN levels_NNS and_CC fold_VB changes_NNS for_IN the_DT
        identification_NN of_IN significant_JJ differentially_RB expressed_VBD
        genes_NNS ._. This_DT simple_JJ model_NN allows_VBZ the_DT experimenter_NN to_TO
        estimate_VB the_DT relationship_NN between_IN these_DT two_CD parameters_NNS in_IN
        the_DT absence_NN of_IN large_JJ numbers_NNS of_IN experimental_JJ replicates_NNS ,_,
        where_WRB the_DT inherent_JJ error_NN of_IN measures_NNS cannot_NN be_VB accurately_RB
        estimated_VBN ._. Subsequently_RB ,_, gene_NN transcripts_NNS determined_VBN to_TO be_VB
        outliers_NNS from_IN the_DT trend_NN can_MD be_VB considered_VBN differentially_RB
        expressed_VBD genes_NNS ._. An_DT added_VBN strength_NN to_TO the_DT model_NN lies_VBZ in_IN its_PRP$
        ease_NN of_IN application_NN to_TO any_DT data_NNS set_VBN ._. This_DT model_NN should_MD be_VB
        considered_VBN a_DT progressive_JJ and_CC cyclical_JJ process_NN ,_, where_WRB the_DT
        data_NNS analyst_NN can_MD quickly_RB and_CC globally_RB identify_VB a_DT list_NN of_IN
        potentially_RB differentially_RB regulated_VBN genes_NNS with_IN confidence_NN ,_,
        based_VBN on_IN the_DT inherent_JJ qualities_NNS of_IN the_DT data_NNS set_VBN under_IN
        evaluation_NN ._.
        The_DT model_NN presented_VBD herein_NN was_VBD developed_VBN with_IN a_DT data_NNS set_VBN
        from_IN a_DT nutritional_JJ experiment_NN in_IN a_DT mouse_NN model_NN using_VBG
        Affymetrix_NNP Mu_NNP 11_CD K_NNP chips_NNS ,_, where_WRB the_DT effects_NNS of_IN four_CD diets_NNS
        were_VBD compared_VBN in_IN a_DT number_NN of_IN organs_NNS (_( pool_NN of_IN five_CD mice_NNS for_IN
        each_DT sample_NN in_IN each_DT organ_NN )_) :_: (_( 1_LS )_) control_NN diet_NN A_DT in_IN duplicate_VB
        from_IN the_DT same_JJ pool_NN ;_: (_( 2_LS )_) diet_NN B_NNP ;_: (_( 3_LS )_) diet_NN C_NNP ;_: and_CC (_( 4_LS )_) diet_NN D_NNP ._.
        Details_NNS of_IN the_DT dietary_JJ treatments_NNS will_MD be_VB reported_VBN
        elsewhere_RB ._. The_DT present_JJ article_NN will_MD take_VB only_RB the_DT data_NNS from_IN
        the_DT liver_NN as_IN an_DT example_NN for_IN the_DT development_NN of_IN a_DT gene_NN
        selection_NN model_NN ._. The_DT model_NN was_VBD validated_JJ by_IN real-time_JJ
        polymerase_NN chain_NN reaction_NN (_( RT-PCR_NNP )_) and_CC indicates_VBZ good_JJ
        concordance_NN between_IN the_DT two_CD experimental_JJ techniques_NNS ._.
      
      
        Results_NNS and_CC Discussion_NNP
        
          Selection_NN of_IN differentially_RB regulated_VBN genes_NNS and_CC
          data_NNS analysis_NN
          The_DT method_NN developed_VBD herein_NN includes_VBZ :_: (_( A_DT )_)
          determination_NN of_IN the_DT upper_JJ X_NNP %_NN of_IN highest_JJS fold_VB changes_NNS
          within_IN narrow_JJ bins_NNS of_IN absolute_JJ expression_NN levels_NNS in_IN order_NN
          to_TO generate_VB a_DT limit_NN fold_VB change_NN (_( LFC_NNP )_) function_NN ;_: and_CC (_( B_NNP )_)
          subsequent_JJ ranking_NN of_IN genes_NNS by_IN a_DT combined_VBN fold_VB
          change_NN /_NN absolute_JJ expression_NN calculation_NN ._. The_DT following_VBG
          discussions_NNS describe_VBP the_DT development_NN of_IN the_DT model_NN within_IN
          the_DT context_NN of_IN our_PRP$ nutritional_JJ study_NN ;_: however_RB ,_, a_DT generic_JJ
          protocol_NN can_MD be_VB found_VBN in_IN the_DT Materials_NNPS and_CC Methods_NNP
          section_NN ._.
        
        
          (_( A_DT )_) Selection_NN of_IN the_DT upper_JJ X_NNP %_NN of_IN highest_JJS fold_VB
          changes_NNS within_IN binned_JJ absolute_JJ expression_NN levels_NNS
          The_DT principal_JJ parameter_NN for_IN gene_NN expression_NN data_NNS
          stemming_VBG from_IN a_DT typical_JJ Affymetrix_NNP experiment_NN is_VBZ the_DT
          average_JJ difference_NN intensity_NN (_( ADI_NNP )_) ,_, which_WDT is_VBZ a_DT
          representation_NN of_IN the_DT absolute_JJ expression_NN of_IN a_DT gene_NN ._. As_IN
          indicated_VBD in_IN the_DT literature_NN ,_, it_PRP is_VBZ common_JJ practice_NN to_TO
          establish_VB a_DT minimal_JJ expression_NN threshold_NN below_IN which_WDT data_NNS
          are_VBP considered_VBN to_TO be_VB noise_NN ._. In_IN the_DT case_NN of_IN Affymetrix_NNP
          data_NNS ,_, it_PRP is_VBZ often_RB necessary_JJ to_TO discard_VB minimal_JJ and_CC
          negative_JJ ADIs_NNP ,_, as_IN these_DT data_NNS are_VBP both_DT biologically_RB and_CC
          mathematically_RB difficult_JJ to_TO interpret_VB ._.
          A_DT number_NN of_IN previous_JJ reports_NNS have_VBP used_VBN an_DT ADI_NNP
          threshold_NN (_( 
          A_DT 
          
            t_NN 
           )_) value_NN of_IN 20_CD in_IN the_DT standard_JJ Affymetrix_NNP range_NN [_NN 13_CD
          14_CD 15_CD 16_CD ]_NN ,_, 
          i_NNP ._. e_SYM ._. probe_NN sets_NNS with_IN ADI_NNP 's_POS of_IN less_JJR
          than_IN 20_CD would_MD either_CC be_VB rejected_VBN or_CC set_VBN to_TO 20_CD as_IN
          meaningful_JJ differences_NNS in_IN gene_NN expression_NN can_MD purportedly_RB
          be_VB evaluated_VBN above_IN this_DT level_NN ._. Although_IN empirically_RB
          supported_VBN ,_, an_DT 
          A_DT 
          
            t_NN 
           of_IN 20_CD is_VBZ essentially_RB an_DT arbitrary_JJ selection_NN and_CC not_RB
          all_DT groups_NNS select_VBP the_DT same_JJ threshold_NN value_NN ._. The_DT exact_JJ
          setting_NN of_IN this_DT lower_VB 
          A_DT 
          
            t_NN 
           is_VBZ not_RB inherent_JJ to_TO the_DT LFC_NNP modeling_NN process_NN ,_, and_CC the_DT
          reader_NN is_VBZ encouraged_VBN to_TO set_VB the_DT 
          A_DT 
          
            t_NN 
           value_NN based_VBN on_IN additional_JJ criteria_NNS ,_, such_JJ as_IN that_DT
          previously_RB published_VBN by_IN Gerhold_NNP 
          et_CC al_NN ._. [_NN 17_CD ]_NN and_CC Dieckgraefe_NNP 
          et_CC al_NN ._. [_NN 18_CD ]_NN ._. However_RB ,_, an_DT 
          A_DT 
          
            t_NN 
           of_IN 20_CD will_MD be_VB used_VBN in_IN the_DT present_JJ work_NN ,_, for_IN which_WDT
          the_DT selection_NN of_IN differentially_RB expressed_VBD genes_NNS in_IN the_DT
          context_NN of_IN ADI_NNP dependent_JJ variance_NN is_VBZ the_DT central_JJ focus_NN ._.
          Therefore_RB ,_, all_DT ADI_NNP 's_POS less_JJR than_IN 20_CD were_VBD set_VBN to_TO 20_CD and_CC any_DT
          probe_NN set_VBN with_IN a_DT value_NN of_IN 20_CD across_IN all_DT dietary_JJ
          treatments_NNS were_VBD discarded_VBN ._. After_IN eliminating_VBG the_DT probe_NN
          sets_NNS which_WDT met_VBD these_DT criteria_NNS there_RB remained_VBD 9391_CD genes_NNS
          out_IN of_IN the_DT original_JJ 13179_CD genes_NNS represented_VBD on_IN the_DT Mu_NNP 11_CD K_NNP
          GeneChip_NNP ._.
          An_DT additional_JJ parameter_NN ,_, highest_JJS fold_VB change_NN (_( HFC_NNP )_) ,_,
          was_VBD then_RB applied_VBN to_TO these_DT remaining_VBG genes_NNS ._. HFC_NNP is_VBZ defined_VBN
          as_IN :_:
          
          where_WRB A_DT ,_, B_NNP ,_, C_NNP ,_, and_CC D_NNP represent_VBP the_DT individual_JJ
          microarray_NN results_NNS for_IN each_DT gene_NN ._. The_DT HFC_NNP is_VBZ inherently_RB a_DT
          ratio_NN metric_NN of_IN the_DT maximum_NN change_NN in_IN measured_VBN gene_NN
          expression_NN between_IN any_DT combination_NN of_IN experimental_JJ
          treatments_NNS ._. The_DT present_JJ experiment_NN has_VBZ four_CD dietary_JJ
          conditions_NNS with_IN microarray_NN data_NNS ;_: however_RB ,_, it_PRP should_MD be_VB
          noted_VBN that_IN the_DT HFC_NNP equation_NN could_MD be_VB expanded_VBN to_TO any_DT
          number_NN of_IN conditions_NNS or_CC experimental_JJ treatments_NNS ._.
          The_DT determination_NN of_IN HFC_NNP is_VBZ highly_RB influenced_VBN by_IN
          absolute_JJ expression_NN ,_, and_CC trends_NNS can_MD be_VB readily_RB observed_VBN
          in_IN our_PRP$ data_NNS set_VBN where_WRB HFC_NNP is_VBZ negatively_RB correlated_JJ with_IN
          absolute_JJ expression_NN (_( Figure_NN 1_CD a_DT )_) ._. For_IN example_NN ,_, with_IN
          absolute_JJ expression_NN values_NNS greater_JJR than_IN 5000_CD it_PRP is_VBZ of_IN low_JJ
          probability_NN to_TO observe_VB an_DT HFC_NNP greater_JJR than_IN 2_CD ._. However_RB ,_,
          with_IN absolute_JJ expression_NN values_NNS near_IN 50_CD ,_, an_DT HFC_NNP of_IN
          greater_JJR than_IN 2_CD is_VBZ readily_RB seen_VBN ._. Although_IN not_RB shown_VBN in_IN
          Figure_NN 1_CD a_DT ,_, this_DT trend_NN could_MD be_VB observed_VBN for_IN any_DT pair_NN or_CC
          triplet_NN of_IN experimental_JJ comparison_NN in_IN the_DT current_JJ data_NN
          set_VBN ,_, 
          i_NNP ._. e_SYM ._. AB_NNP ,_, AC_NNP ,_, AD_NNP ,_, BC_NNP ,_, BD_NNP ,_, ABC_NNP ,_, BCD_NNP ._.
          It_PRP has_VBZ also_RB been_VBN observed_VBN across_IN multiple_JJ experiments_NNS
          examined_VBD in_IN our_PRP$ laboratory_NN (_( data_NNS not_RB shown_VBN )_) ._. This_DT
          consistancy_NN can_MD be_VB explained_VBN by_IN the_DT fact_NN that_IN there_EX are_VBP
          very_RB few_JJ genes_NNS out_IN of_IN the_DT entire_JJ transcriptome_NN which_WDT are_VBP
          differentially_RB expressed_VBN due_JJ to_TO treatment_NN ._. Therefore_RB ,_,
          most_RBS measured_VBN gene_NN transcripts_NNS display_VBP a_DT typical_JJ
          coefficient_NN of_IN variation_NN independent_JJ of_IN treatment_NN ._. The_DT
          few_JJ genes_NNS which_WDT are_VBP differentially_RB expressed_VBN do_VBP not_RB
          unduly_RB affect_VB the_DT overall_JJ trend_NN ._. Therefore_RB ,_, the_DT trend_NN
          lends_VBZ itself_PRP to_TO characterization_NN and_CC may_MD be_VB used_VBN as_IN a_DT
          metric_NN for_IN determining_VBG differential_NN gene_NN expression_NN
          across_IN multiple_JJ experiments_NNS ._.
          This_DT empirically_RB implies_VBZ that_IN natural_JJ variation_NN ,_,
          expressed_VBD here_RB as_IN HFC_NNP ,_, tends_VBZ to_TO be_VB much_RB greater_JJR at_IN low_JJ
          expression_NN levels_NNS ._. This_DT concept_NN is_VBZ supported_VBN in_IN the_DT
          literature_NN [_NN 12_CD ]_NN and_CC questions_VBZ the_DT appropriateness_NN of_IN
          using_VBG a_DT linear_JJ fold_VB change_NN cut-off_JJ in_IN a_DT system_NN
          characterized_VBN by_IN heterogenous_JJ variance_NN ._.
          As_IN stated_VBN previously_RB ,_, the_DT selection_NN of_IN differentially_RB
          expressed_VBD genes_NNS is_VBZ essentially_RB a_DT search_NN for_IN outliers_NNS ,_, 
          i_NNP ._. e_SYM ._. gene_NN data_NNS lying_VBG outside_IN some_DT
          standard_JJ distribution_NN of_IN differences_NNS relative_JJ to_TO a_DT
          control_NN state_NN ,_, and_CC which_WDT cannot_NN be_VB ascribed_VBN to_TO chance_NN or_CC
          natural_JJ variabilty_NN ._. To_TO determine_VB those_DT genes_NNS which_WDT are_VBP
          outliers_NNS ,_, it_PRP is_VBZ necessary_JJ to_TO measure_VB either_CC the_DT
          variability_NN of_IN the_DT system_NN or_CC to_TO make_VB valid_JJ assumptions_NNS
          regarding_VBG the_DT distribution_NN of_IN variability_NN ._. In_IN the_DT present_JJ
          model_NN we_PRP assume_VBP that_IN :_: (_( 1_LS )_) as_IN mentioned_VBN above_IN ,_, variability_NN
          in_IN the_DT measurement_NN of_IN gene_NN expression_NN is_VBZ related_VBN to_TO the_DT
          ADI_NNP ;_: and_CC (_( 2_LS )_) if_IN a_DT broad_JJ sampling_VBG of_IN the_DT transcriptome_NN is_VBZ
          measured_VBN ,_, only_RB a_DT small_JJ number_NN of_IN genes_NNS will_MD actually_RB be_VB
          outliers_NNS even_RB in_IN the_DT harshest_JJS of_IN experimental_JJ conditions_NNS ._.
          Assumption_NNP (_( 1_LS )_) is_VBZ a_DT fairly_RB general_JJ analytical_JJ concept_NN ,_, 
          i_NNP ._. e_SYM ._. the_DT closer_JJR data_NN is_VBZ to_TO the_DT
          measurement_NN threshold_NN ,_, the_DT higher_JJR the_DT variability_NN is_VBZ in_IN
          that_DT measurement_NN [_NN 12_CD 19_CD ]_NN ._. Assumption_NNP (_( 2_LS )_) appears_VBZ to_TO be_VB
          empiricaly_RB valid_JJ when_WRB surveying_VBG the_DT literature_NN for_IN
          high-density_JJ microarray_NN experiments_NNS which_WDT evaluate_VBP severe_JJ
          biological_JJ events_NNS ,_, from_IN caloric_JJ restriction_NN [_NN 20_CD 21_CD ]_NN to_TO
          apoptosis_NNS [_NN 22_CD 23_CD ]_NN ._. In_IN these_DT experiments_NNS [_NN 20_CD 21_CD 22_CD 23_CD
          ]_NN ,_, regardless_RB of_IN the_DT gene_NN selection_NN method_NN used_VBD ,_, less_JJR
          than_IN 5_CD %_NN of_IN the_DT total_JJ number_NN of_IN genes_NNS probed_JJ were_VBD
          differentially_RB regulated_VBN ._. Therefore_RB ,_, to_TO develop_VB the_DT
          present_JJ model_NN of_IN gene_NN selection_NN ,_, the_DT validity_NN of_IN
          selecting_VBG outliers_NNS was_VBD evaluated_VBN for_IN a_DT range_NN of_IN highly_RB
          variable_JJ genes_NNS using_VBG the_DT top_JJ 5_CD %_NN as_IN a_DT benchmark_NN ._. Model_NNP
          trends_NNS were_VBD then_RB examined_VBN from_IN 1_CD %_NN to_TO 10_CD %_NN ._.
          The_DT model_NN was_VBD developed_VBN by_IN first_JJ binning_VBG gene_NN
          expression_NN data_NNS into_IN tight_JJ classes_NNS across_IN the_DT entire_JJ
          range_NN of_IN absolute_JJ expression_NN values_NNS ,_, where_WRB genes_NNS with_IN an_DT
          equal_JJ absolute_JJ expression_NN value_NN were_VBD randomly_RB ordered_VBN ,_,
          and_CC then_RB selecting_VBG the_DT upper_JJ 5_CD %_NN of_IN HFC_NNP values_NNS for_IN further_JJ
          consideration_NN ._. Binning_NNP was_VBD carried_VBN out_IN to_TO divide_VB the_DT
          entire_JJ range_NN of_IN absolute_JJ expression_NN values_NNS into_IN bins_NNS
          containing_VBG an_DT equal_JJ number_NN ,_, 
          m_NN ,_, of_IN genes_NNS ,_, where_WRB 
          m_NN =_SYM 200_CD ._. Therefore_RB ,_, bin_NN widths_NNS
          (_( ADI_NNP )_) were_VBD not_RB necessarily_RB equal_JJ ,_, yet_RB the_DT number_NN of_IN genes_NNS
          contained_VBD in_IN each_DT bin_NN was_VBD equivalent_NN ._. For_IN the_DT first_JJ round_NN
          of_IN analysis_NN ,_, the_DT upper_JJ 5_CD %_NN ,_, or_CC 95_CD thpercentile_NN ,_, of_IN HFC_NNP
          genes_NNS in_IN each_DT bin_NN were_VBD selected_VBN for_IN further_JJ consideration_NN
          (_( Figure_NN 1_CD a_DT )_) ._. It_PRP was_VBD possible_JJ to_TO search_VB separately_RB for_IN the_DT
          5_CD %_NN of_IN genes_NNS with_IN the_DT greatest_JJS HFCs_NNP in_IN each_DT class_NN ;_:
          however_RB ,_, in_IN order_NN to_TO simplify_VB the_DT overall_JJ selection_NN ,_, we_PRP
          plotted_VBD the_DT relationship_NN between_IN absolute_JJ expression_NN ,_,
          defined_VBN as_IN min_NN ADI_NNP (_( A_DT ,_, B_NNP ,_, C_NNP ,_, D_NNP )_) ,_, and_CC HFC_NNP ,_, in_IN order_NN to_TO set_VB
          the_DT LFC_NNP function_NN ._. Herein_NNP ,_, the_DT min_NN ADI_NNP (_( A_DT ,_, B_NNP ,_, C_NNP ,_, D_NNP )_) will_MD
          simply_RB be_VB referred_VBN to_TO as_IN min_NN ADI_NNP ._. This_DT relationship_NN was_VBD
          then_RB modeled_VBN using_VBG a_DT simple_JJ equation_NN of_IN the_DT form_NN 
          LFC_NNP =_SYM a_DT +_NN (_( b_SYM /_NN min_NN ADI_NNP )_) ,_, which_WDT is_VBZ
          fitted_JJ to_TO the_DT 95_CD thpercentile_NN of_IN each_DT bin_NN (_( Figure_NN 1_CD a_DT )_) to_TO
          produce_VB the_DT LFC_NNP curve_NN that_IN best_JJS models_NNS the_DT expression_NN
          data_NN ._. This_DT modeled_VBD LFC_NNP curve_NN (_( 5_CD %_NN LFC_NNP model_NN =_SYM 1_CD ._. 74_CD +_NN
          91_CD ._. 55_CD /_NN min_NN ADI_NNP )_) fit_VB the_DT data_NNS well_RB (_( R_NN 2_CD =_SYM 0_CD ._. 98_CD )_) and_CC further_JJ
          analysis_NN indicated_VBD the_DT residuals_NNS were_VBD randomly_RB
          distributed_VBN (_( data_NNS not_RB shown_VBN )_) ._. The_DT equation_NN for_IN the_DT line_NN
          of_IN best_JJS fit_VB contains_VBZ two_CD parameters_NNS that_WDT have_VBP various_JJ
          repercussions_NNS on_IN gene_NN selection_NN ,_, both_DT of_IN which_WDT can_MD be_VB
          defined_VBN in_IN commercially_RB available_JJ software_NN using_VBG common_JJ
          "_'' solve_VB "_'' functions_NNS (_( 
          e_SYM ._. g_SYM ._. Microsoft_NNP Excel_NNP )_) ._. First_LS ,_, 
          a_DT sets_VBZ the_DT asymptote_NN ,_, which_WDT
          corresponds_NNS to_TO the_DT minimum_JJ HFC_NNP value_NN that_WDT can_MD be_VB observed_VBN
          at_IN any_DT given_VBN ADI_NNP ._. Second_JJ ,_, 
          b_SYM raises_VBZ /_NN lowers_VBZ the_DT limit_NN function_NN
          at_IN a_DT given_VBN ADI_NNP ,_, and_CC is_VBZ therefore_RB highly_RB influenced_VBN by_IN
          this_DT latter_JJ value_NN ._. For_IN example_NN ,_, the_DT smaller_JJR the_DT ADI_NNP the_DT
          greater_JJR the_DT LFC_NNP ,_, and_CC vice_NN versa_RB ._. Figure_NN 1_CD bshows_NNS that_IN as_IN
          the_DT selection_NN criteria_NNS becomes_VBZ more_RBR strict_JJ (_( top_JJ 5_CD %_NN →_NN 1_CD %_NN
          of_IN genes_NNS )_) ,_, the_DT curve_NN shifts_NNS (_( 1_CD %_NN LFC_NNP model_NN =_SYM 2_CD ._. 43_CD +_NN
          166_CD ._. 12_CD /_NN min_NN ADI_NNP )_) and_CC becomes_VBZ more_RBR restrictive_JJ in_IN the_DT
          selection_NN of_IN differential_NN genes_NNS ,_, 
          i_NNP ._. e_SYM ._. at_IN any_DT given_VBN absolute_JJ
          expression_NN level_NN a_DT higher_JJR fold_VB change_NN must_MD be_VB observed_VBN
          for_IN a_DT gene_NN to_TO be_VB considered_VBN differentially_RB expressed_VBD ._. The_DT
          opposite_NN is_VBZ true_JJ when_WRB the_DT selection_NN criteria_NNS becomes_VBZ less_RBR
          strict_JJ (_( top_JJ 5_CD %_NN →_NN 10_CD %_NN of_IN genes_NNS )_) ,_, where_WRB the_DT curve_NN shifts_NNS
          (_( 10_CD %_NN LFC_NNP model_NN =_SYM 1_CD ._. 59_CD +_NN 69_CD ._. 47_CD /_NN min_NN ADI_NNP )_) and_CC results_NNS in_IN a_DT
          more_RBR permissive_JJ selection_NN of_IN differential_NN genes_NNS ._.
          Using_VBG the_DT aforementioned_JJ equations_NNS the_DT selection_NN of_IN
          genes_NNS for_IN further_JJ consideration_NN becomes_VBZ simple_JJ and_CC
          '_POS global_JJ '_POS (_( 
          i_NNP ._. e_SYM ._. across_IN the_DT entire_JJ range_NN of_IN
          expression_NN levels_NNS )_) ;_: where_WRB a_DT gene_NN is_VBZ selected_VBN with_IN the_DT HFC_NNP
          approach_NN if_IN max_NN ADI_NNP /_NN min_NN ADI_NNP >_NN a_DT +_NN (_( b_SYM /_NN min_NN ADI_NNP )_) ._. After_IN
          applying_VBG the_DT 10_CD %_NN LFC_NNP gene_NN filter_NN ,_, 869_CD genes_NNS remained_VBD in_IN
          the_DT list_NN out_IN of_IN the_DT 9391_CD candidate_NN genes_NNS selected_VBN from_IN
          the_DT original_JJ 13179_CD genes_NNS on_IN the_DT GeneChip_NNP ._. When_WRB interested_JJ
          in_IN the_DT top_JJ 5_CD %_NN and_CC 1_CD %_NN of_IN significant_JJ genes_NNS ,_, the_DT total_JJ
          number_NN of_IN genes_NNS that_WDT meet_VBP the_DT LFC_NNP requirements_NNS is_VBZ 471_CD and_CC
          82_CD ,_, respectively_RB ._.
          Lastly_NNP it_PRP should_MD be_VB noted_VBN that_IN the_DT LFC_NNP ,_, 
          i_NNP ._. e_SYM ._. the_DT modeled_VBN trend_NN of_IN HFC_NNP vs_NNS ._.
          min_NN ADI_NNP ,_, is_VBZ based_VBN on_IN binned_JJ data_NNS of_IN hundreds_NNS of_IN genes_NNS
          across_IN multiple_JJ conditions_NNS leading_VBG to_TO a_DT highly_RB powerful_JJ
          characterization_NN of_IN a_DT given_VBN threshold_NN ._. In_IN other_JJ words_NNS ,_,
          there_EX is_VBZ a_DT large_JJ amount_NN of_IN data_NNS available_JJ in_IN order_NN to_TO
          accurately_RB characterize_VB the_DT trend_NN ._. The_DT same_JJ argument_NN
          holds_VBZ for_IN the_DT generation_NN of_IN a_DT modeled_VBN confidence_NN interval_NN
          based_VBN on_IN low_JJ numbers_NNS of_IN replicates_NNS ,_, as_IN will_MD be_VB described_VBN
          below_IN ._. This_DT is_VBZ in_IN contrast_NN to_TO the_DT relatively_RB low_JJ
          statistical_JJ power_NN of_IN conventional_JJ "_'' gene-by-gene_JJ "_'' tests_NNS
          such_JJ as_IN the_DT 
          t_NN -_: test_NN or_CC ANOVA_NNP ,_, often_RB used_VBN for_IN
          the_DT selection_NN of_IN differentially_RB expressed_VBD genes_NNS [_NN 8_CD ]_NN
          ._.
        
        
          (_( B_NNP )_) Assignment_NNP of_IN gene_NN rank_NN
          Following_VBG gene_NN selection_NN ,_, a_DT rank_NN of_IN '_POS importance_NN '_'' or_CC
          '_POS interest_NN level_NN '_'' was_VBD assigned_VBN to_TO each_DT selected_VBN gene_NN ._. It_PRP
          should_MD be_VB noted_VBN that_IN the_DT LFC_NNP is_VBZ not_RB dependent_JJ on_IN the_DT rank_NN
          calculation_NN ;_: rather_RB rank_NN simply_RB lends_VBZ relative_JJ
          '_POS importance_NN '_'' to_TO selected_VBN genes_NNS by_IN incorporating_VBG both_DT the_DT
          magnitude_NN of_IN fold_VB change_NN and_CC absolute_JJ expression_NN values_NNS ._.
          The_DT rank_NN number_NN (_( RN_NNP )_) for_IN each_DT gene_NN was_VBD determined_VBN by_IN
          first_JJ calculating_VBG a_DT rank_NN value_NN (_( RV_NN )_) ,_, which_WDT can_MD be_VB defined_VBN
          as_IN :_: RV_NN =_SYM HFC_NNP *_NN (_( max_NN ADI_NNP -_: min_NN ADI_NNP )_) ._. After_IN calculation_NN of_IN
          RV_NN ,_, gene_NN lists_NNS were_VBD sorted_VBN and_CC then_RB assigned_VBN a_DT simple_JJ RN_NNP
          of_IN 1_CD ,_, 2_CD ,_, 3_CD ,_, 4_CD ._. ._. ._. ,_, where_WRB a_DT gene_NN with_IN a_DT RN_NNP of_IN 1_CD corresponds_NNS to_TO
          the_DT gene_NN with_IN the_DT highest_JJS RV_NN ._. The_DT RV_NN is_VBZ an_DT arbitrary_JJ
          value_NN that_WDT simply_RB lends_VBZ importance_NN to_TO selected_VBN genes_NNS with_IN
          both_DT high_JJ fold_VB changes_NNS and_CC high_JJ differences_NNS in_IN absolute_JJ
          expression_NN ._. Both_DT RV_NN and_CC RN_NNP aid_NN in_IN the_DT discussion_NN of_IN
          differential_NN gene_NN effects_NNS by_IN adding_VBG the_DT concept_NN of_IN
          relative_JJ weight_NN or_CC importance_NN amongst_IN selected_VBN genes_NNS ._.
          This_DT concept_NN aids_NNS in_IN the_DT choice_NN of_IN genes_NNS for_IN validation_NN
          or_CC follow-up_JJ studies_NNS ,_, as_IN detailed_JJ below_IN ._.
        
        
          (_( C_NNP )_) Model_NNP validation_NN
          
            Validation_NNP of_IN the_DT LFC_NNP model_NN via_IN characterization_NN
            of_IN measurement_NN variability_NN
            Hess_NNP and_CC colleagues_NNS have_VBP recently_RB examined_VBN the_DT
            concept_NN that_DT variability_NN and_CC absolute_JJ expression_NN are_VBP
            related_VBN ;_: however_RB ,_, they_PRP examined_VBD only_RB the_DT variability_NN of_IN
            replicate_VB spots_NNS on_IN a_DT single_JJ slide_NN [_NN 24_CD ]_NN ._. Herein_NNP ,_, we_PRP
            extended_VBD this_DT concept_NN to_TO examine_VB the_DT variability_NN
            between_IN genes_NNS on_IN different_JJ microarrays_NNS ._. Measurement_NNP
            variance_NN was_VBD examined_VBN following_VBG the_DT development_NN of_IN the_DT
            LFC_NNP model_NN ,_, and_CC was_VBD therefore_RB used_VBN simply_RB as_IN a_DT
            confirmation_NN of_IN this_DT model_NN ._. To_TO further_VB understand_VB the_DT
            nature_NN of_IN measurement_NN variability_NN within_IN the_DT current_JJ
            study_NN ,_, duplicate_VB Mu_NNP 11_CD K_NNP Affymetrix_NNP microarrays_NNS for_IN the_DT
            controls_NNS were_VBD examined_VBN (_( see_VB Materials_NNPS and_CC Methods_NNP
            section_NN )_) ._. A_DT pooled_VBN RNA_NNP sample_NN from_IN mice_NNS (_( 
            n_NN =_SYM 5_LS )_) fed_VBD the_DT control_NN diet_NN was_VBD
            hybridized_JJ to_TO two_CD different_JJ chips_NNS ,_, and_CC the_DT data_NNS was_VBD
            analyzed_VBN to_TO characterize_VB measurement_NN variability_NN ._. It_PRP
            was_VBD apparent_JJ from_IN the_DT trend_NN that_IN as_IN absolute_JJ expression_NN
            levels_NNS (_( ADI_NNP )_) increase_NN ,_, the_DT coefficient_NN of_IN variation_NN
            (_( CV_NNP =_SYM SD_NNP /_NN MAE_NNP )_) decreases_NNS ._. The_DT trendline_NN was_VBD calculated_VBN as_IN
            detailed_JJ in_IN the_DT Materials_NNPS and_CC Methods_NNP section_NN ._. This_DT
            trendline_NN was_VBD overlayed_JJ on_IN the_DT entire_JJ data_NN set_VBN ,_, in_IN
            addition_NN to_TO the_DT 5_CD %_NN LFC_NNP selected_VBD data_NNS (_( shown_VBN in_IN red_JJ )_) ,_, in_IN
            Figure_NN 1_CD c_SYM ._. By_IN overlaying_VBG the_DT trendline_NN of_IN the_DT within_IN
            variability_NN data_NNS on_IN those_DT genes_NNS determined_VBN to_TO be_VB
            significantly_RB regulated_VBN by_IN the_DT LFC_NNP model_NN ,_, the_DT CV_NNP upper_JJ
            confidence_NN limit_NN for_IN these_DT selected_VBN genes_NNS had_VBD a_DT 
            p_NN value_NN ≤_NN 0_CD ._. 001_CD ._. Thus_RB ,_, the_DT 5_CD %_NN
            LFC-selected_NNP data_NNS lies_VBZ outside_IN the_DT 99_CD ._. 9_CD %_NN confidence_NN
            interval_NN surrounding_VBG measurement_NN variability_NN ,_,
            reinforcing_VBG the_DT validity_NN of_IN the_DT results_NNS ._.
          
          
            Real-time_NNP polymerase_NN chain_NN reaction_NN
            (_( RT-PCR_NNP )_)
            The_DT results_NNS obtained_VBN from_IN a_DT microarray_NN experiment_NN
            are_VBP influenced_VBN by_IN each_DT step_NN in_IN the_DT experimental_JJ
            procedure_NN ,_, from_IN array_NN manufacturing_NN to_TO sample_NN
            preparation_NN and_CC application_NN to_TO image_NN analysis_NN [_NN 25_CD ]_NN ._.
            The_DT preparation_NN of_IN the_DT cRNA_NN sample_NN is_VBZ highly_RB correlated_JJ
            to_TO the_DT efficiency_NN of_IN the_DT reverse_JJ transcription_NN step_NN ,_,
            where_WRB reagents_NNS and_CC enzymes_NNS alike_RB can_MD influence_VB the_DT
            reaction_NN outcome_NN ._. These_DT factors_NNS affect_VBP the_DT
            representation_NN of_IN transcripts_NNS in_IN the_DT cRNA_NN sample_NN ,_,
            necessitating_VBG the_DT need_NN for_IN validations_NNS by_IN complementary_JJ
            techniques_NNS ._. Analyses_NNS by_IN northern_JJ blot_NN and_CC RNAse_NNP
            protection_NN assays_NNS are_VBP commonly_RB reported_VBN ;_: however_RB ,_, the_DT
            emerging_VBG '_POS gold-standard_JJ '_POS validation_NN technique_NN is_VBZ RT-PCR_NNP
            [_NN 26_CD ]_NN ._. Microarrays_NNP tend_VBP to_TO have_VB a_DT low_JJ dynamic_JJ range_NN ,_,
            which_WDT can_MD lead_VB to_TO small_JJ yet_RB significant_JJ
            under-representations_JJ of_IN fold_VB changes_NNS in_IN gene_NN
            expression_NN [_NN 27_CD ]_NN ._. As_IN RT-PCR_NNP has_VBZ a_DT greater_JJR dynamic_JJ
            range_NN ,_, it_PRP is_VBZ often_RB used_VBN to_TO validate_NN the_DT observed_VBD trends_NNS
            rather_RB than_IN duplicate_VB the_DT fold_VB changes_NNS obtained_VBN by_IN chip_NN
            experiments_NNS [_NN 26_CD 28_CD 29_CD ]_NN ._.
            Having_VBG chosen_VBN genes_NNS that_WDT lie_VBP across_IN the_DT range_NN of_IN RN_NNP ,_,
            and_CC therefore_RB the_DT range_NN of_IN model_NN selection_NN criteria_NNS ,_,
            RT-PCR_NNP was_VBD performed_VBN in_IN triplicate_NN for_IN each_DT
            experimental_JJ condition_NN (_( Diet_NNP A_DT ,_, B_NNP ,_, C_NNP ,_, D_NNP )_) using_VBG the_DT same_JJ
            pooled_VBN stocks_NNS of_IN liver_NN RNA_NNP (_( 5_CD mice_NNS per_IN experiment_NN )_) ._.
            Genes_NNP were_VBD compared_VBN to_TO the_DT endogenous_JJ controls_NNS β-actin_JJ
            and_CC GAPDH_NNP ,_, which_WDT did_VBD not_RB significantly_RB change_VB across_IN
            the_DT dietary_JJ treatments_NNS ._. As_IN determined_VBN by_IN our_PRP$ LFC_NNP
            selection_NN model_NN ,_, the_DT GeneChip_NNP microarrays_NNS indicated_VBD no_DT
            significant_JJ differences_NNS amongst_IN the_DT 4_CD diets_NNS for_IN either_DT
            GAPDH_NNP or_CC β-actin_JJ ._. Subsequent_JJ confirmation_NN that_IN both_DT
            GAPDH_NNP and_CC β-actin_JJ did_VBD not_RB change_NN was_VBD provided_VBN by_IN
            RT-PCR_NNP ,_, where_WRB a_DT simple_JJ student_NN 's_POS 
            t_NN -_: test_NN with_IN a_DT predefined_JJ nominal_JJ
            α_NN level_NN of_IN 0_CD ._. 05_CD indicated_VBD no_DT significant_JJ differences_NNS
            between_IN the_DT experimental_JJ diets_NNS (_( B_NNP ,_, C_NNP ,_, D_NNP )_) and_CC the_DT control_NN
            diet_NN A_DT ._. RT-PCR_NNP provided_VBD a_DT means_NN to_TO confirm_VB the_DT effects_NNS
            of_IN the_DT 3_CD dietary_JJ treatments_NNS on_IN 9_CD genes_NNS (_( Table_NNP 1_LS )_) and_CC
            the_DT concordance_NN between_IN these_DT 27_CD microarray_NN and_CC RT-PCR_NNP
            results_NNS was_VBD examined_VBN ._. Perfect_NNP concordance_NN was_VBD not_RB to_TO be_VB
            expected_VBN due_JJ to_TO the_DT inherent_JJ differences_NNS in_IN sensitivity_NN
            and_CC dynamic_JJ range_NN between_IN the_DT two_CD techniques_NNS ._. However_RB ,_,
            a_DT good_JJ overall_JJ concordance_NN of_IN 77_CD ._. 7_CD %_NN for_IN differential_NN
            gene_NN expression_NN was_VBD observed_VBN ,_, 
            i_NNP ._. e_SYM ._. the_DT fold_VB change_NN for_IN a_DT given_VBN
            gene_NN seen_VBN by_IN microarray_NN was_VBD directionally_RB consistent_JJ
            with_IN that_DT seen_VBN by_IN RT-PCR_NNP ,_, regardless_RB whether_IN the_DT
            results_NNS were_VBD significant_JJ by_IN either_DT the_DT 5_CD %_NN LFC_NNP model_NN
            (_( for_IN microarray_NN data_NNS )_) or_CC a_DT student_NN 's_POS T-_NNP test_NN (_( for_IN RT-PCR_NNP
            data_NNS )_) ._. When_WRB examining_VBG only_RB those_DT genes_NNS considered_VBN
            significantly_RB changed_VBN by_IN RT-PCR_NNP (_( α_NN =_SYM 0_CD ._. 05_CD ,_, starred_JJ
            values_NNS in_IN Table_NNP 1_LS )_) ,_, concordance_NN increases_NNS to_TO 85_CD ._. 7_CD %_NN ._.
            Therefore_RB ,_, the_DT value_NN of_IN 85_CD ._. 7_CD %_NN indicates_VBZ the_DT overall_JJ
            concordance_NN between_IN significantly_RB changed_VBN genes_NNS seen_VBN by_IN
            RT-PCR_NNP and_CC those_DT microarray_NN pairwise_NN comparisons_NNS
            (_( treatment_NN vs_NNS ._. control_NN )_) that_WDT meet_VBP the_DT LFC_NNP model_NN
            criteria_NNS (_( §_NN values_NNS in_IN Table_NNP 1_LS )_) ._.
            What_WP is_VBZ noticeable_JJ through_IN the_DT color_NN scheme_NN (_( Table_NNP
            1_LS )_) is_VBZ genes_NNS with_IN high_JJ RN_NNP (_( low_JJ RV_NN )_) have_VBP relatively_RB less_JJR
            concordance_NN between_IN the_DT two_CD techniques_NNS ;_: where_WRB red_JJ
            indicates_VBZ no_DT concordance_NN and_CC blue_JJ indicates_VBZ only_RB one_CD or_CC
            two_CD (_( out_IN of_IN three_CD )_) of_IN the_DT results_NNS agreed_VBD ._. However_RB ,_, the_DT
            majority_NN of_IN genes_NNS are_VBP colored_VBN in_IN green_JJ ,_, indicating_VBG
            perfect_JJ directional_NN concordance_NN ._. When_WRB specifically_RB
            examining_VBG fatty_NN acid_NN synthase_NN (_( FAS_NNP )_) ,_, a_DT highly_RB expressed_VBN
            gene_NN ,_, microarray_NN fold_VB changes_NNS of_IN less_JJR than_IN 2_CD can_MD be_VB
            corroborated_JJ between_IN the_DT two_CD experimental_JJ techniques_NNS ,_,
            reinforcing_VBG the_DT strength_NN of_IN this_DT fold_VB change_NN model_NN ._.
            Furthermore_RB ,_, it_PRP is_VBZ clear_JJ from_IN the_DT RT-PCR_NNP data_NN that_IN at_IN
            very_RB low_JJ expression_NN levels_NNS ,_, high_JJ fold_VB changes_NNS are_VBP still_RB
            problematic_JJ to_TO verify_VB and_CC remain_VB questionable_JJ ._. The_DT
            present_JJ model_NN takes_VBZ this_DT into_IN account_NN by_IN raising_VBG the_DT
            criteria_NNS appropriately_RB at_IN the_DT low_JJ expression_NN range_NN ,_, 
            i_NNP ._. e_SYM ._. a_DT higher_JJR fold_VB change_NN at_IN low_JJ
            expression_NN levels_NNS is_VBZ required_VBN for_IN a_DT gene_NN to_TO be_VB
            considered_VBN differentially_RB expressed_VBD ._.
            As_IN the_DT selection_NN criteria_NNS with_IN microarray_NN data_NNS was_VBD
            that_IN the_DT HFC_NNP must_MD be_VB greater_JJR than_IN the_DT LFC_NNP model_NN limits_NNS ,_,
            the_DT expectation_NN was_VBD that_IN the_DT LFC_NNP function_NN could_MD be_VB
            validated_JJ by_IN RT-PCR_NNP (_( underlined_VBD values_NNS in_IN Table_NNP
            1_CD indicate_VBP HFC_NNP for_IN each_DT gene_NN )_) ._. This_DT is_VBZ predominantly_RB the_DT
            case_NN across_IN the_DT full_JJ dynamic_JJ range_NN of_IN data_NNS selected_VBN by_IN
            the_DT model_NN (_( 77_CD ._. 7_CD %_NN /_NN 85_CD ._. 7_CD %_NN concordance_NN )_) ,_, except_IN for_IN very_RB
            lowly_JJ expressed_VBD genes_NNS such_JJ as_IN the_DT RAS_NNP oncogene_NN ._. For_IN
            genes_NNS with_IN a_DT slightly_RB lower_JJR RN_NNP (_( higher_JJR RV_NN )_) ,_, such_JJ as_IN
            ABC_NNP 1_CD member_NN 7_CD ,_, some_DT concordance_NN is_VBZ seen_VBN ,_, indicating_VBG
            confidence_NN is_VBZ gaining_VBG as_IN RV_NN increases_NNS ._. For_IN genes_NNS with_IN
            an_DT RN_NNP lower_JJR than_IN 130_CD (_( RV_NN >_NN 1156_CD ;_: 
            e_SYM ._. g_SYM ._. USF-_NNP 2_LS )_) concordance_NN quickly_RB
            approaches_VBZ 100_CD %_NN ,_, indicating_VBG high_JJ confidence_NN when_WRB
            discussing_VBG gene_NN trends_NNS or_CC individual_JJ gene_NN results_NNS ._.
            These_DT results_NNS reinforce_VBP the_DT concept_NN that_IN RN_NNP is_VBZ
            correlated_JJ with_IN confidence_NN and_CC validity_NN when_WRB discussing_VBG
            the_DT gene_NN set_VBN produced_VBN by_IN the_DT LFC_NNP model_NN ._.
            Interestingly_RB ,_, one_PRP might_MD expect_VB that_IN genes_NNS with_IN an_DT
            RN_NNP lower_JJR then_RB 130_CD would_MD be_VB concentrated_VBN only_RB at_IN higher_JJR
            expression_NN levels_NNS ;_: however_RB ,_, when_WRB the_DT spread_NN of_IN genes_NNS
            with_IN an_DT RN_NNP between_IN 1_CD -_: 130_CD were_VBD examined_VBN ,_, these_DT genes_NNS
            were_VBD found_VBN to_TO lie_VB across_IN the_DT entire_JJ range_NN of_IN absolute_JJ
            expressions_NNS (_( data_NNS not_RB shown_VBN )_) ._. This_DT indicates_VBZ that_IN a_DT 5_CD %_NN
            LFC_NNP model_NN is_VBZ confidently_RB selecting_VBG differentially_RB
            regulated_VBN genes_NNS across_IN the_DT full_JJ range_NN of_IN absolute_JJ
            expression_NN ._. Therefore_RB ,_, the_DT 5_CD %_NN LFC_NNP model_NN appears_VBZ to_TO be_VB
            an_DT appropriate_JJ selection_NN criteria_NNS for_IN the_DT present_JJ
            experimental_JJ data_NNS set_VBN ;_: however_RB ,_, the_DT fold_VB change_NN
            percentage_NN could_MD easily_RB be_VB varied_VBN to_TO meet_VB other_JJ
            acceptable_JJ levels_NNS of_IN risk_NN ,_, as_IN is_VBZ done_VBN with_IN conventional_JJ
            hypothesis_NNS testing_NN (_( 
            e_SYM ._. g_SYM ._. α-_NN ,_, 
            p_NN -_: ,_, and_CC χ_NN 2_CD -_: values_NNS )_) ._. The_DT X_NNP %_NN
            selection_NN criteria_NNS should_MD then_RB be_VB re-evaluated_JJ for_IN
            other_JJ experimental_JJ data_NNS sets_NNS in_IN relation_NN to_TO the_DT
            variance_NN and_CC validation_NN data_NNS at_IN hand_NN ._.
          
        
      
      
        Conclusions_NNP
        The_DT analysis_NN of_IN microarray_NN data_NNS is_VBZ a_DT developing_VBG field_NN of_IN
        study_NN aimed_VBN at_IN enabling_VBG the_DT biomedical_JJ community_NN to_TO cope_VB
        with_IN the_DT waves_NNS of_IN large_JJ microarray_NN data_NNS sets_NNS ._. Already_RB ,_, an_DT
        evolution_NN can_MD be_VB observed_VBN with_IN respect_NN to_TO the_DT methods_NNS for_IN
        selecting_VBG significantly_RB changed_VBN genes_NNS ._. Researchers_NNS are_VBP
        moving_VBG away_RB from_IN simple_JJ fold_VB change_NN cut-offs_JJ and_CC
        incorporating_VBG the_DT use_NN of_IN robust_JJ statistical_JJ concepts_NNS ._. The_DT
        conclusion_NN that_IN highly_RB expressed_VBD genes_NNS will_MD rarely_RB have_VB a_DT
        2_CD -_: fold_VB change_NN in_IN mRNA_NN levels_NNS and_CC that_IN lowly_JJ expressed_VBD genes_NNS
        will_MD commonly_RB have_VB a_DT greater_JJR than_IN 2_CD -_: fold_VB change_NN led_VBN to_TO the_DT
        development_NN of_IN a_DT model_NN that_WDT would_MD accommodate_VB for_IN this_DT real_JJ
        biological_JJ characteristic_NN of_IN gene_NN expression_NN measurements_NNS ._.
        The_DT fold_VB change_NN model_NN presented_VBN in_IN this_DT paper_NN considers_VBZ
        both_DT the_DT absolute_JJ expression_NN level_NN and_CC fold_VB change_NN of_IN every_DT
        gene_NN across_IN the_DT entire_JJ range_NN of_IN observed_VBD absolute_JJ
        expressions_NNS ._. In_IN addition_NN ,_, the_DT concept_NN of_IN increased_VBN
        variation_NN in_IN lowly_JJ expressed_VBD genes_NNS is_VBZ incorporated_VBN into_IN the_DT
        selection_NN model_NN through_IN the_DT higher_JJR fold_VB change_NN requirements_NNS
        for_IN differential_NN gene_NN selection_NN at_IN low_JJ expression_NN levels_NNS ._.
        Following_VBG gene_NN selection_NN using_VBG an_DT initial_JJ criterion_NN of_IN X_NNP %_NN ,_,
        gene_NN rank_NN was_VBD introduced_VBN as_IN a_DT basis_NN for_IN choosing_VBG genes_NNS to_TO
        validate_NN the_DT model_NN ._. Therefore_RB ,_, a_DT limited_JJ but_CC judicious_JJ
        choice_NN of_IN model_NN parameters_NNS to_TO select_VB genes_NNS across_IN a_DT broad_JJ
        range_NN of_IN gene_NN rank_NN can_MD then_RB be_VB used_VBN to_TO reset_VB the_DT X_NNP %_NN in_IN
        order_NN to_TO correspond_VB with_IN the_DT data_NNS at_IN hand_NN (_( Figure_NN 2_LS )_) ._. The_DT
        variance_NN data_NN characterizing_VBG measurement_NN variability_NN
        supports_VBZ the_DT selection_NN model_NN ,_, indicating_VBG that_WDT selected_VBD
        genes_NNS lie_VBP outside_JJ measurement_NN variability_NN at_IN very_RB high_JJ
        confidence_NN limits_NNS (_( >_NN 99_CD ._. 9_CD %_NN CL_NNP )_) ._. Further_RB validation_NN of_IN
        this_DT model_NN in_IN the_DT current_JJ data_NN set_VBN by_IN RT-PCR_NNP confirmed_VBD
        these_DT relationships_NNS ,_, reinforcing_VBG that_IN genes_NNS with_IN fold_VB
        changes_NNS even_RB less_JJR than_IN 1_CD ._. 8_CD can_MD be_VB measured_VBN ,_, assuming_VBG
        adequate_JJ absolute_JJ expression_NN levels_NNS ._. This_DT demonstrates_VBZ that_IN
        biological_JJ changes_NNS in_IN sample_NN concentration_NN of_IN mRNA_NN ,_, even_RB at_IN
        low_JJ fold_VB change_NN levels_NNS ,_, can_MD be_VB confidently_RB determined_VBN ._.
        In_IN summary_NN ,_, the_DT X_NNP %_NN LFC_NNP model_NN enables_VBZ one_CD to_TO define_VB
        experiment_NN specific_JJ selection_NN stringency_NN while_IN maintaining_VBG
        simplicity_NN and_CC ensuring_VBG global_JJ coverage_NN for_IN the_DT detection_NN
        of_IN differential_NN gene_NN selection_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Mice_NNS and_CC feeding_NN conditions_NNS
          Mice_NNS were_VBD male_JJ Rj_NNP :_: NMRI_NNP mice_NNS from_IN Elevage_NNP Janvier_NNP ,_, Le_NNP
          Genest-_NNP Saint-_NNP Isle_NNP France_NNP ,_, weighing_VBG 10_CD -_: 11_CD g_SYM at_IN delivery_NN
          and_CC 33_CD -_: 51_CD grams_NNS on_IN day_NN 42_CD ,_, were_VBD housed_VBN 10_CD per_IN cage_NN ._. Mice_NNS
          received_VBD 
          ad_NN libitum_NN quantities_NNS of_IN bottled_JJ
          distilled_VBN water_NN and_CC purified_JJ powdered_JJ diets_NNS (_( 7_CD ._. 5_LS g_SYM /_NN mouse_NN )_)
          in_IN ceramic_JJ cups_NNS (_( 10_CD /_NN group_NN )_) for_IN 42_CD d_SYM ._. Experimental_NNP diets_NNS
          will_MD be_VB described_VBN in_IN detail_NN in_IN a_DT biological_JJ follow_VB up_RB
          publication_NN ._.
        
        
          Dissection_NNP of_IN mice_NNS
          After_IN administration_NN of_IN the_DT aforementioned_JJ diets_NNS to_TO 10_CD
          mice_NNS per_IN group_NN ,_, 5_CD mice_NNS were_VBD randomly_RB selected_VBN for_IN
          inclusion_NN in_IN the_DT gene_NN expression_NN analysis_NN experiment_NN ._.
          Organs_NNP were_VBD dissected_VBN according_VBG to_TO standard_JJ protocols_NNS ,_,
          then_RB cut_VB into_IN 100_CD -_: 150_CD mg_NN subsections_NNS ,_, flash_VBP frozen_VBN in_IN
          liquid_JJ nitrogen_NN ,_, and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP until_IN gene_NN
          expression_NN analysis_NN ._.
        
        
          Nucleic_NNP acid_NN preparation_NN
          Tissue_NNP from_IN each_DT organ_NN was_VBD extracted_VBN from_IN 5_CD individual_JJ
          mice_NNS and_CC extracted_VBN separately_RB using_VBG Qiagen_NNP RNeasy_NNP
          mini-kits_JJ (_( Basel_NNP ,_, Switzerland_NNP )_) according_VBG to_TO
          manufacturer_NN 's_POS instructions_NNS with_IN one_CD exception_NN :_: During_IN
          extractions_NNS ,_, all_DT RNeasy_NNP columns_NNS were_VBD impregnated_JJ with_IN
          DNase_NNP I_PRP (_( Roche_NNP ,_, Basel_NNP ,_, Switzerland_NNP )_) to_TO remove_VB possible_JJ
          genomic_JJ DNA_NNP contamination_NN ._. After_IN extraction_NN ,_, equal_JJ
          amounts_NNS of_IN material_NN were_VBD pooled_VBN to_TO obtain_VB 10_CD μg_NN total_JJ RNA_NNP
          per_IN dietary_JJ group_NN ._. RNA_NNP samples_NNS were_VBD quantified_VBN with_IN the_DT
          RiboGreen_NNP RNA_NNP Quantification_NNP Kit_NNP according_VBG to_TO
          manufacturer_NN 's_POS instructions_NNS (_( Molecular_NNP Probes_NNP ,_, Eugene_NNP
          Oregon_NNP )_) ,_, and_CC then_RB analyzed_VBD via_IN agarose_NN gel_NN
          electrophoresis_NNS for_IN intact_JJ 18_CD and_CC 28_CD s_VBZ rRNA_NN ._. All_DT samples_NNS
          included_VBN in_IN the_DT study_NN were_VBD judged_VBN to_TO contain_VB high-quality_JJ
          RNA_NNP in_IN sufficient_JJ amounts_NNS for_IN hybridization_NN ._.
        
        
          Gene_NNP expression_NN analysis_NN using_VBG the_DT murine_NN 11_CD k_NN
          GeneChip_NNP
          
            cRNA_NN preparation_NN
            Total_NNP RNA_NNP (_( 15_CD μg_NN )_) was_VBD used_VBN as_IN starting_VBG material_NN for_IN
            all_DT samples_NNS ._. In_IN all_DT cases_NNS ,_, a_DT "_'' test_NN chip_NN "_'' provided_VBN by_IN
            the_DT manufacturer_NN was_VBD run_VBN prior_RB to_TO using_VBG the_DT Murine_NNP 11_CD k_NN
            GeneChip_NNP ._. In_IN each_DT case_NN this_DT confirmed_VBD that_IN sufficient_JJ
            high_JJ quality_NN RNA_NNP was_VBD present_JJ to_TO detect_VB gene_NN expression_NN
            in_IN the_DT various_JJ tissue_NN samples_NNS ._. The_DT first_JJ and_CC second_JJ
            strand_NN cDNA_NN synthesis_NN was_VBD performed_VBN using_VBG the_DT
            SuperScript_NNP Choice_NNP System_NNP (_( Life_NNP Technologies_NNPS )_) according_VBG
            to_TO manufacturer_NN 's_POS instructions_NNS ,_, but_CC using_VBG oligo-d_JJ T_NN
            primer_NN containing_VBG a_DT T_NN 7_CD RNA_NNP polymerase_NN binding_JJ site_NN ._.
            Labeled_NNP cRNA_NN was_VBD prepared_VBN using_VBG the_DT MEGAscript_NNP ,_, 
            In_IN Vitro_NNP Transcription_NNP kit_NN
            (_( Ambion_NNP )_) ._. Biotin_NNP labeled_VBD CTP_NNP and_CC UTP_NNP (_( Enzo_NNP )_) was_VBD used_VBN
            together_RB with_IN unlabeled_JJ NTP_NNP 's_POS in_IN the_DT reaction_NN ._.
            Following_VBG the_DT 
            in_IN vitro_NN transcription_NN reaction_NN ,_,
            unincorporated_JJ nucleotides_NNS were_VBD removed_VBN using_VBG RNeasy_NNP
            columns_NNS (_( Qiagen_NNP )_) ._.
          
          
            Array_NNP hybridization_NN and_CC scanning_VBG
            cRNA_NN (_( 10_CD μg_NN )_) was_VBD fragmented_JJ at_IN 94_CD °_NN C_NNP for_IN 35_CD min_NN in_IN
            buffer_NN containing_VBG 40_CD mM_NN /_NN L_NNP Tris-acetate_NNP pH_NN 8_CD ._. 1_CD ,_, 100_CD mM_NN /_NN L_NNP
            KOAc_NNP ,_, 30_CD mM_NN /_NN L_NNP MgOAc_NNP ._. Prior_RB to_TO hybridization_NN ,_, fragmented_JJ
            cRNA_NN in_IN a_DT 6_CD ×_NN SSPE-T_NNP hybridization_NN buffer_NN (_( 1_CD M_NNP /_NN L_NNP NaCl_NNP ,_, 10_CD
            mM_NN Tris_NNP pH_NN 7_CD ._. 6_CD ,_, 0_CD ._. 005_CD %_NN Triton_NNP )_) ,_, was_VBD heated_VBN to_TO 95_CD °_NN C_NNP for_IN
            5_CD min_NN ,_, cooled_VBN to_TO 40_CD °_NN C_NNP ,_, and_CC then_RB loaded_VBN onto_IN the_DT
            Affymetrix_NNP probe_NN array_NN cartridge_NN ._. The_DT probe_NN array_NN was_VBD
            incubated_JJ for_IN 16_CD h_NN at_IN 40_CD °_NN C_NNP at_IN 60_CD rpm_NN ._. The_DT probe_NN array_NN
            was_VBD washed_VBN 10_CD ×_NN in_IN 6_CD ×_NN SSPE-T_NNP at_IN 25_CD °_NN C_NNP followed_VBN by_IN 4_CD washes_NNS
            in_IN 0_CD ._. 5_CD ×_NN SSPE-T_NNP at_IN 50_CD °_NN C_NNP ._. The_DT biotinylated_JJ cRNA_NN was_VBD
            stained_JJ with_IN a_DT streptavidin-phycoerythrin_JJ conjugate_NN ,_, 10_CD
            g_SYM /_NN ml_NN (_( Molecular_NNP Probes_NNP )_) in_IN 6_CD ×_NN SSPE-T_NNP for_IN 30_CD min_NN at_IN 25_CD °_NN C_NNP
            followed_VBN by_IN 10_CD washes_NNS in_IN 6_CD ×_NN SSPE-T_NNP at_IN 25_CD °_NN C_NNP ._. The_DT probe_NN
            arrays_NNS were_VBD scanned_JJ at_IN 560_CD nm_NN using_VBG a_DT confocal_NN
            laser-scanning_JJ microscope_NN (_( made_VBN for_IN Affymetrix_NNP by_IN
            Hewlett-_NNP Packard_NNP )_) ._. Readings_NNP from_IN the_DT quantitative_JJ
            scanning_VBG were_VBD analyzed_VBN with_IN Affymetrix_NNP Gene_NNP Expression_NNP
            Analysis_NNP Software_NNP ._.
          
        
        
          A_DT step-by-step_JJ method_NN to_TO apply_VB the_DT LFC_NNP model_NN to_TO an_DT
          experimental_JJ data_NN set_VBN
          
            1_LS ._. Data_NNP handling_VBG and_CC 2_CD -_: dimensional_NN
            visualization_NN
            Overall_RB ,_, the_DT values_NNS of_IN all_DT genes_NNS are_VBP compared_VBN across_IN
            any_DT number_NN (_( 
            p_NN )_) of_IN experimental_JJ conditions_NNS ._.
            The_DT absolute_JJ expression_NN value_NN of_IN the_DT 
            k_NN -_: th_NN gene_NN for_IN the_DT 
            j_NN -_: th_NN treatment_NN is_VBZ coded_VBN Z_NNP 
            
              kj_NN 
             ._. When_WRB considering_VBG any_DT given_VBN gene_NN ,_, the_DT following_VBG
            data-handling_JJ rules_NNS are_VBP applied_VBN :_:
            •_NN All_DT values_NNS below_IN an_DT ADI_NNP threshold_NN (_( 
            A_DT 
            
              t_NN 
             )_) are_VBP set_VBN to_TO 
            A_DT 
            
              t_NN 
             ._.
            •_NN If_IN the_DT values_NNS for_IN gene_NN 
            k_NN are_VBP 
            A_DT 
            
              t_NN 
             for_IN all_DT 
            p_NN treatments_NNS ,_, the_DT gene_NN is_VBZ defined_VBN
            as_RB not_RB expressed_VBD and_CC is_VBZ n't_RB considered_VBN further_RB ._.
            •_NN The_DT absolute_JJ expression_NN value_NN for_IN gene_NN 
            k_NN is_VBZ defined_VBN as_IN 
            min_NN (_( 
            Z_NNP 
            
            k_NN 1_CD ,_, ._. ._. ._. ,_, 
            Z_NNP 
            
              kp_NN 
             )_) ._.
            •_NN The_DT highest_JJS fold_VB change_NN (_( HFC_NNP )_) of_IN gene_NN 
            k_NN is_VBZ defined_VBN as_IN the_DT
            following_VBG :_:
            
            When_WRB visualizing_VBG all_DT genes_NNS on_IN a_DT bivariate_NN plot_NN
            according_VBG to_TO absolute_JJ expression_NN and_CC fold_VB change_NN ,_, one_CD
            obtains_NNS a_DT data_NNS distribution_NN similar_JJ to_TO that_DT of_IN Figure_NN
            1_CD a_DT ._.
          
          
            2_LS ._. Modeling_NNP a_DT discrete_JJ limit_NN fold_VB change_NN
            model_NN
            The_DT goal_NN is_VBZ to_TO select_VB the_DT upper_JJ X_NNP %_NN of_IN genes_NNS with_IN
            highest_JJS fold_VB change_NN across_IN the_DT entire_JJ range_NN of_IN
            expression_NN levels_NNS ._. Therefore_RB ,_, the_DT following_VBG rules_NNS are_VBP
            applied_VBN :_:
            •_NN Genes_NNP are_VBP ordered_VBN according_VBG to_TO their_PRP$ absolute_JJ
            expression_NN value_NN 
            min_NN (_( 
            Z_NNP 
            
            k_NN 1_CD ,_, ._. ._. ._. ,_, 
            Z_NNP 
            
              kp_NN 
             )_) ,_, where_WRB equally_RB expressed_VBD genes_NNS are_VBP randomly_RB
            ordered_VBN ._.
            •_NN The_DT overall_JJ expression_NN range_NN is_VBZ divided_VBN into_IN bins_NNS
            of_IN different_JJ width_NN ,_, but_CC containing_VBG an_DT equal_JJ number_NN 
            m_NN of_IN genes_NNS ._.
            •_NN In_IN each_DT bin_NN ,_, the_DT (_( 1_CD -_: X_NNP )_) -_: percentile_NN fold_VB change_NN
            corresponding_JJ to_TO a_DT fold_VB change_NN that_WDT is_VBZ exceeded_VBN by_IN X_NNP %_NN
            of_IN genes_NNS in_IN the_DT bin_NN is_VBZ determined_VBN ._. For_IN X_NNP %_NN between_IN 1_CD %_NN
            and_CC 10_CD %_NN ,_, 
            m_NN =_SYM 200_CD appears_VBZ to_TO be_VB
            suitable_JJ ._.
            When_WRB visualizing_VBG the_DT (_( 1_CD -_: X_NNP )_) -_: percentile_NN fold_VB change_NN in_IN
            each_DT bin_NN ,_, one_CD obtains_NNS a_DT data_NNS distribution_NN similar_JJ to_TO
            that_DT seen_VBN in_IN Figure_NN 1_CD a_DT ._.
          
          
            3_LS ._. Modeling_NNP a_DT continuous_JJ limit_NN fold_VB change_NN (_( LFC_NNP )_)
            model_NN
            A_DT continuous_JJ model_NN is_VBZ derived_VBN from_IN the_DT discrete_JJ one_CD
            by_IN relating_VBG the_DT mean_NN expressions_NNS of_IN each_DT bin_NN with_IN the_DT
            corresponding_JJ (_( 1_CD -_: X_NNP )_) -_: limit_NN fold_VB change_NN ,_, using_VBG a_DT least_JJS
            squares_NNS fit_NN of_IN the_DT equation_NN :_:
            (_( 1_CD -_: X_NNP )_) -_: LFC_NNP =_SYM 
            a_DT +_NN 
            b_SYM /_NN Z_NNP (_( minimum_JJ expression_NN )_)
            This_DT equation_NN appears_VBZ to_TO fit_VB the_DT data_NNS very_RB well_RB and_CC ,_,
            the_DT interpretation_NN of_IN the_DT parameters_NNS (_( 
            a_DT and_NN 
            b_SYM )_) is_VBZ straightforward_JJ :_:
            •_NN Parameter_NNP 
            a_DT represents_VBZ the_DT asymptote_NN of_IN the_DT
            curve_NN ._. For_IN very_RB large_JJ expressions_NNS ,_, the_DT (_( 1_CD -_: 
            X_NNP )_) -_: limit_NN fold_VB change_NN tends_VBZ to_TO be_VB
            equal_JJ to_TO parameter_NN 
            a_DT ._.
            •_NN Parameter_NNP 
            b_SYM is_VBZ proportional_JJ to_TO the_DT
            difference_NN between_IN the_DT (_( 1_CD -_: X_NNP )_) -_: limit_NN fold_VB change_NN of_IN small_JJ
            and_CC high_JJ expressions_NNS ._.
            When_WRB visualizing_VBG this_DT continuous_JJ limit_NN fold_VB change_NN
            model_NN ,_, one_CD obtains_NNS a_DT curve_NN similar_JJ to_TO that_DT observed_VBD in_IN
            Figure_NN 1_CD a_DT ._. In_IN addition_NN ,_, increasing_VBG the_DT (_( 1_CD -_: X_NNP )_) -_: percentile_NN
            fold_VB change_NN shifts_NNS the_DT curve_NN up_RP the_DT 
            y_NN -_: axis_NNS and_CC results_NNS in_IN an_DT
            increased_VBN stringency_NN for_IN gene_NN selection_NN ,_, 
            i_NNP ._. e_SYM ._. fewer_JJR genes_NNS meet_VBP the_DT LFC_NNP
            requirement_NN (_( Figure_NN 1_CD b_SYM )_) ._.
          
          
            Validation_NNP by_IN Coefficient_NNP of_IN Variance_NNP
            For_IN experiments_NNS that_WDT are_VBP performed_VBN without_IN
            replicates_NNS ,_, the_DT LFC-model_NNP selects_VBZ genes_NNS with_IN the_DT
            highest_JJS between-treatment_JJ variability_NN (_( previously_RB
            defined_VBN as_IN fold_VB change_NN )_) at_IN any_DT expression_NN level_NN ._. If_IN
            replicates_NNS are_VBP available_JJ ,_, the_DT inherent_JJ error_NN of_IN
            measures_NNS ,_, the_DT within-treatment_JJ variability_NN ,_, can_MD be_VB
            estimated_VBN ._. Therefore_RB ,_, it_PRP becomes_VBZ possible_JJ to_TO select_VB the_DT
            genes_NNS with_IN the_DT highest_JJS ratio_NN of_IN
            between-treatment-variability_JJ /_NN
            within-treatment-variability_JJ ._.
            In_IN the_DT data_NNS set_VBN that_WDT was_VBD used_VBN for_IN illustrating_VBG the_DT
            development_NN of_IN the_DT LFC-model_NNP ,_, duplicate_VB measures_NNS were_VBD
            available_JJ for_IN one_CD of_IN the_DT four_CD treatments_NNS ._. The_DT
            within-treatment-variability_JJ appears_VBZ to_TO be_VB highly_RB
            dependent_JJ of_IN the_DT expression_NN level_NN of_IN the_DT gene_NN ,_,
            confirming_VBG the_DT findings_NNS of_IN Hess_NNP 
            et_CC al_NN ._. [_NN 24_CD ]_NN ._.
            In_IN order_NN to_TO estimate_VB the_DT CV_NNP without_IN taking_VBG into_IN
            account_NN extreme_JJ values_NNS of_IN the_DT duplicate_VB we_PRP used_VBD a_DT
            robust_JJ estimator_NN ,_, represented_VBN by_IN the_DT following_JJ
            equation_NN :_:
            
            where_WRB the_DT χ_NN 
            
              inverse_NN 
             function_NN returns_VBZ the_DT inverse_NN of_IN the_DT one-tailed_JJ
            probability_NN of_IN the_DT χ-squared_JJ distribution_NN ._.
            Applying_VBG the_DT CV_NNP derived_VBD from_IN replicate_VB sample_NN data_NNS (_(
            
            eqn_NN ._. 2_LS )_) to_TO the_DT quadruplicate_NN
            diet_NN data_NNS enabled_VBD the_DT calculation_NN of_IN the_DT CV_NNP upper_JJ
            confidence_NN level_NN (_( by_IN bins_NNS of_IN absolute_JJ expression_NN level_NN )_)
            using_VBG the_DT following_JJ equation_NN :_:
            
            where_WRB the_DT χ_NN 
            
              inverse_NN 
             function_NN returns_VBZ the_DT inverse_NN of_IN the_DT one-tailed_JJ
            probability_NN of_IN the_DT χ-squared_JJ distribution_NN ._.
            
            Eqn_NNP ._. 3_LS allows_VBZ one_CD to_TO identify_VB
            genes_NNS with_IN a_DT variance_NN above_IN measurement_NN variability_NN ._.
            This_DT greater_JJR variability_NN arose_VBD due_JJ to_TO combined_VBN pool_NN
            (_( biological_JJ )_) and_CC treatment_NN variabilities_NNS ._.
            This_DT confidence_NN level_NN could_MD be_VB raised_VBN or_CC lowered_VBD
            according_VBG to_TO the_DT level_NN of_IN confidence_NN desired_VBN by_IN
            altering_VBG the_DT 
            p_NN value_NN ._. Therefore_RB ,_, modeling_VBG the_DT
            variance_NN data_NN provides_VBZ a_DT complimentary_JJ method_NN for_IN
            examining_VBG the_DT variation_NN of_IN genes_NNS across_IN the_DT complete_JJ
            range_NN of_IN absolute_JJ expression_NN values_NNS ._.
            The_DT upper_JJ 99_CD ._. 9_CD %_NN confidence_NN limit_NN (_( CL_NNP )_) of_IN a_DT robust_JJ
            estimation_NN of_IN the_DT coefficient_NN of_IN variance_NN (_( CV_NNP )_) for_IN
            replicates_NNS (_( within-treatment_JJ variability_NN )_) has_VBZ been_VBN
            modeled_VBN as_IN a_DT function_NN of_IN absolute_JJ minimum_JJ expression_NN of_IN
            all_DT treatments_NNS using_VBG the_DT following_JJ model_NN :_:
            Upper_NNP 99_CD ._. 9_CD %_NN CL_NNP =_SYM 
            c_SYM +_NN 
            d_SYM /_NN mean_NN expression_NN
            The_DT selected_VBN genes_NNS are_VBP now_RB those_DT for_IN which_WDT the_DT CV_NNP of_IN
            treatment_NN expressions_NNS (_( between-treatment_JJ variability_NN )_)
            is_VBZ larger_JJR than_IN this_DT limit_NN (_( Figure_NN 1_CD c_SYM )_) ._. By_IN overlapping_VBG
            those_DT genes_NNS selected_VBN by_IN the_DT LFC_NNP model_NN (_( red_JJ dots_NNS )_) on_IN the_DT
            graph_NN indicating_VBG the_DT 99_CD ._. 9_CD %_NN CL_NNP (_( blue_JJ line_NN )_) ,_, one_CD observes_VBZ
            that_IN the_DT LFC_NNP model_NN is_VBZ considerably_RB more_RBR restrictive_JJ
            when_WRB selecting_VBG lowly_JJ expressed_VBD genes_NNS (_( Figure_NN 1_CD c_SYM )_) ._.
          
          
            Validation_NNP by_IN real-time_JJ PCR_NNP (_( RT-PCR_NNP )_)
            A_DT subset_NN of_IN differentially_RB expressed_VBD genes_NNS were_VBD
            selected_VBN to_TO confirm_VB the_DT LFC_NNP model_NN ,_, where_WRB genes_NNS were_VBD
            selected_VBN across_IN the_DT range_NN of_IN absolute_JJ expressions_NNS and_CC
            with_IN varying_VBG fold_VB changes_NNS ._. Although_IN not_RB discussed_VBN in_IN
            the_DT present_JJ manuscript_NN ,_, a_DT good_JJ description_NN of_IN the_DT
            technique_NN and_CC an_DT example_NN of_IN an_DT excellent_JJ experimental_JJ
            design_NN can_MD be_VB found_VBN in_IN previous_JJ publications_NNS [_NN 26_CD 30_CD ]_NN
            ,_, respectively_RB ._. In_IN brief_JJ ,_, all_DT genes_NNS were_VBD amplified_VBN in_IN
            the_DT Applied_NNP Biosystems_NNP 5700_CD instrument_NN using_VBG SYBR_NNP
            ®_NN green_JJ (_( Molecular_NNP Probes_NNP )_) ,_, a_DT dye_NN that_WDT binds_NNS
            double-stranded_JJ DNA_NNP ._. Data_NNP represented_VBD means_NNS of_IN
            triplicates_NNS for_IN each_DT experimental_JJ treatment_NN using_VBG
            pooled_VBN RNA_NNP samples_NNS (_( 
            n_NN =_SYM 5_LS )_) ._. Amplification_NNP was_VBD
            performed_VBN using_VBG an_DT ABI_NNP 5700_CD machine_NN (_( Applied_NNP
            Biosystems_NNP ,_, Foster_NNP City_NNP ,_, CA_NNP ,_, USA_NNP )_) with_IN a_DT hot_JJ start_NN at_IN
            95_CD °_NN C_NNP for_IN 10_CD minutes_NNS ,_, followed_VBN by_IN 40_CD cycles_NNS of_IN 95_CD °_NN C_NNP for_IN
            15_CD s_VBZ and_CC 60_CD °_NN C_NNP for_IN 1_CD min_NN for_IN denaturation_NN ,_, annealing_VBG and_CC
            elongation_NN ._. Genes_NNP were_VBD normalized_JJ to_TO either_CC β-actin_JJ or_CC
            GAPDH_NNP ,_, and_CC then_RB experimental_JJ diets_NNS (_( B_NNP ,_, C_NNP ,_, D_NNP )_) were_VBD
            compared_VBN to_TO the_DT control_NN diet_NN (_( A_DT )_) ._. All_DT fold_VB changes_NNS were_VBD
            subjected_VBN to_TO a_DT student_NN 's_POS 
            t_NN -_: test_NN (_( α_NN =_SYM 0_CD ._. 05_CD )_) to_TO ensure_VB fold_VB
            changes_NNS observed_VBN by_IN RT-PCR_NNP were_VBD statistically_RB
            significant_JJ ._. Comparisons_NNP between_IN microarray_NN data_NNS and_CC
            RT-PCR_NNP were_VBD then_RB performed_VBN ._.
          
        
      
      
        Abbreviations_NNP
        
        CV_NNP :_: coefficient_NN of_IN variation_NN
        
        FC_NNP :_: fold_VB change_NN
        
        HFC_NNP :_: highest_JJS fold_VB change_NN
        
        LFC_NNP :_: limit_NN fold_VB change_NN function_NN
        
        MAE_NNP :_: mean_VB absolute_JJ expression_NN
        
        RN_NNP :_: rank_NN number_NN
        
        RT-PCR_NNP :_: real_JJ time_NN polymerase_NN chain_NN
        reaction_NN
        
        RV_NN :_: rank_NN value_NN
        
        SD_NNP :_: standard_JJ deviation_NN
      
      
        Definitions_NNP
        
        Average_NNP Difference_NNP Intensity_NNP
        (_( ADI_NNP )_) :_: average_JJ measure_NN of_IN intensity_NN of_IN hybridization_NN
        for_IN a_DT series_NN of_IN match_NN and_CC mismatch_NN probe_NN pairs_NNS tiled_JJ across_IN
        a_DT particular_JJ gene_NN transcript_NN ._. ADI_NNP is_VBZ an_DT indicator_NN of_IN the_DT
        absolute_JJ expression_NN of_IN a_DT gene_NN ._.
        
        Concordance_NNP :_: state_NN of_IN agreement_NN between_IN
        two_CD complementary_JJ measurement_NN techniques_NNS which_WDT is_VBZ
        directionally_RB consistent_JJ ,_, 
        e_SYM ._. g_SYM ._. two_CD techniques_NNS determine_VBP that_IN
        values_NNS are_VBP statistically_RB significant_JJ and_CC that_IN they_PRP are_VBP both_DT
        either_CC positive_JJ or_CC negative_JJ ._.
      
      
        Author_NN contributions_NNS
        DM_NNP integrated_VBN the_DT mathematical_JJ and_CC biological_JJ
        interpretation_NN of_IN the_DT experiment_NN that_WDT resulted_VBD in_IN the_DT
        writing_NN of_IN this_DT manuscript_NN ._. AR_NNP and_CC RM_NNP developed_VBD the_DT
        mathematical_JJ formula_NN describing_VBG the_DT limit_NN fold_VB change_NN
        model_NN ._. AB_NNP and_CC MR_NNP designed_VBD and_CC carried_VBN out_RP the_DT DNA_NNP
        microarray_NN studies_NNS in_IN mice_NNS ._. MR_NNP initiated_VBD the_DT development_NN of_IN
        robust_JJ mathematical_JJ techniques_NNS to_TO evaluate_VB microarray_NN data_NNS
        at_IN the_DT Nestlé_NNP Research_NNP Center_NNP ._.
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
